Powered by

Kamada Announces Preliminary Revenue for Fourth Quarter and Full-Year 2018

Jan 02, 2019 - GlobeNewswire

Full-Year 2018 Revenue Expected to be Between $113 Million and $115 Million

Anticipated Revenues Exceed Current Revenue Guidance of $102 Million to $108 Million

Expected Full-Year 2018 Total Revenue Would Represent Increase of Between 10% and 12% Over Full-Year 2017 Revenue

Company Reaffirms Full-Year 2019 Total Revenue Guidance of $125 Million to $130 Million

REHOVOT, Israel, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein...